Biotech’s New Frontiers: Therapies, Losses, and Legacy
Kilder
- Bioworld: First PROTAC: Arvinas’ Veppanu wins FDA nod in breast cancer - BioWorld News
- fiercepharma.com: FDA hands Pfizer, Arvinas’ Veppanu early approval for breast cancer subtype - Fierce Pharma
- stocktitan.net: FDA clears Arvinas (NASDAQ: ARVN) VEPPANU for advanced breast cancer - Stock Titan
- statnews.com: Axsome wins FDA nod for Alzheimer’s agitation - statnews.com
- biospace.com: Axsome wins first non-antipsychotic FDA approval for Alzheimer’s agitation - BioSpace
- bioworld.com: Axsome’s Auvelity cleared for large Alzheimer’s agitation market - BioWorld News
- Genengnews: Going Non-Viral: Gene Delivery Enters Its Translation Era - Genetic Engineering and Biotechnology News
- genengnews.com: Going Non-Viral: Gene Delivery Enters Its Translation Era - Genetic Engineering and Biotechnology News
- genengnews.com: Figurate SCADA System Launched to Overcome Digital Bottlenecks During Biopharma Manufacturing - Genetic Engineering and Biotechnology News
- genengnews.com: Smarter AAVs Drive Gene Therapy’s Next Chapter - Genetic Engineering and Biotechnology News
- Fiercebiotech: J&J axes $5B CAR-T dream months after touting best-in-disease efficacy - Fierce Biotech
- fiercebiotech.com: J&J axes $5B CAR-T dream months after touting best-in-disease efficacy - Fierce Biotech
- Biospace: Moderna beats revenue expectations with $389M, but litigation dogs earnings - BioSpace
- biospace.com: Moderna beats revenue expectations with $389M, but litigation dogs earnings - BioSpace
- nature.com: Genome pioneer Craig Venter dies: here’s how he transformed science - Nature
- statnews.com: Remembering J. Craig Venter: a relentless scientist who changed biotech — and was all too easily misunderstood - statnews.com
- wikimedia: Photo by Medgirl131 / Wikimedia Commons / CC BY-SA 4.0
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.